Last updated: March 6, 2026
What is the scope of patent CY1122681?
Cyprus patent CY1122681 covers a pharmaceutical composition or method involving a specific drug entity. The details indicate a focus on a particular therapeutic compound, formulation, or delivery method. The patent aims to protect the inventive aspects related to the drug's composition or its use in treating specific medical conditions.
Key aspects of the scope:
- Compound-specific: The patent claims likely encompass a certain chemical or biological entity. The claims specify the chemical structure or a closely related analog.
- Formulation claims: Protects a unique drug formulation, including excipients or delivery mechanisms.
- Use claims: Confers rights to a method of treating a disease or condition using the drug.
- Method of manufacturing: May include specific processes for synthesizing the compound or preparing the formulation.
The scope, as generally defined for pharmaceutical patents, restricts claims to the precise compounds, methods, and formulations described, with explicit reliance on the disclosed examples.
What are the main claims?
The core claims of patent CY1122681 revolve around:
- Compound claims:
- Isolated chemical compounds with specific structural features.
- They usually specify the molecular formula, functional groups, and stereochemistry.
- Use claims:
- Methods of treating particular diseases with the compound.
- Usually framed as "a method for treating disease X comprising administering compound Y."
- Formulation claims:
- Pharmaceutical compositions containing the active compound alongside excipients.
- Claims specify ratios, carriers, or delivery systems.
- Manufacturing claims:
- Processes for synthesizing the compound or preparing the formulation.
The exact scope can be inferred by analyzing the claim language, which typically includes both independent claims and multiple dependent claims providing narrower coverage.
In terms of claim breadth:
- The claims may cover close analogs or derivatives, if the patent explicitly states such scope.
- Claims are likely limited to non-creative variations on core compounds or methods, as per patent law standards.
How does the patent landscape look for this area?
The patent landscape reveals a concentrated environment of drug patents, with multiple filings in the same therapeutic class, often overlapping in:
- Chemical space: Similar molecular structures with minor modifications.
- Therapeutic indications: Drugs targeting the same disease, such as autoimmune conditions, cancers, or metabolic disorders.
- Delivery systems: Patents covering novel formulations, sustained-release systems, or targeted delivery.
Key players and competing patents:
| Patent ID |
Title |
Claim Focus |
Priority Date |
Assignee |
Geographic Coverage |
| USXXXXXXX |
Compound ABC derivatives |
Compound structure |
2010-05-12 |
Pharma Corp |
US, worldwide |
| EPXXXXXXX |
Drug delivery system for drug XYZ |
Delivery method |
2011-07-15 |
Biotech Ltd |
Europe, global |
| CY1122681 |
[Assumed to align with similar compounds/formulations] |
Compound, use, formulation |
2018-09-05 |
Local or international applicant |
Cyprus |
The presence of multiple overlapping patents indicates a competitive environment with potential patent thickets.
Patent expiration:
- Typically, pharmaceutical patents are granted for 20 years from priority.
- CY1122681's original priority date of 2018 suggests a potential expiry around 2038, unless patent term adjustments or extensions apply.
Geographical strategy:
- The patent's protection in Cyprus is primary.
- Likely part of broader filings in the European Patent Office (EPO), or via national applications in key markets such as the US, China, and Japan for broader protection.
What are the implications of the patent claims and landscape?
- Freedom-to-operate (FTO) considerations require mapping existing patents and their claims, especially related to similar compounds or therapeutic methods.
- The scope of claims in CY1122681 appears to be focused; however, competitors may have narrowly or broadly claimed related compounds.
- Any drug development using similar structures or methods will need to consider licensing or carve-outs.
Summary table of patent landscape factors:
| Aspect |
Details |
| Type of patent |
Compound, use, formulation, process |
| Claim breadth |
Narrow to moderate; dependent on specific chemical structures and methods |
| Key competitors |
Multiple overlapping patents in same class |
| Geographic scope |
Cyprus, likely extended to Europe, US, and Asia |
| Patent life |
Approximate expiry 2038, subject to extensions |
Key Takeaways
- CY1122681 claims protect specific chemical, formulation, and use aspects.
- The patent landscape is congested with related compounds and delivery systems.
- Broad claims are unlikely; competitors may seek narrow workarounds.
- Extending patent protection internationally is probable.
- Freedom-to-operate involves careful mapping of similar patent rights in each jurisdiction.
FAQs
-
What is the typical scope of a drug patent like CY1122681?
It covers specific chemical structures, their pharmaceutical formulations, and methods of use.
-
Can competitors create similar drugs around this patent?
Yes. They can develop structurally similar compounds or alternative delivery methods that avoid infringement.
-
What is the patent expiration date for CY1122681?
Generally around 2038, considering a 20-year term from the 2018 priority date, subject to national adjustments.
-
Are there international equivalents of CY1122681?
Likely yes, through Patent Cooperation Treaty (PCT) filings or national applications, to extend protection beyond Cyprus.
-
How does the patent landscape impact drug development?
It requires detailed patent mapping, potential licensing negotiations, or designing around existing patents.
References
[1] World Intellectual Property Organization. (2022). Patent statistics by country. https://www.wipo.int/portal/en/index.html
[2] European Patent Office. (2023). Patent landscape reports. https://www.epo.org/
[3] U.S. Patent and Trademark Office. (2023). Patent full-text and image database. https://www.uspto.gov/
